Microangiopathic hemolytic anemia natural history, complications and prognosis: Difference between revisions
(Created page with "__NOTOC__ {{Microangiopathic hemolytic anemia}} Please help WikiDoc by adding content here. It's easy! Click here to learn about editing. ==R...") |
MydahSajid (talk | contribs) No edit summary |
||
Line 2: | Line 2: | ||
{{Microangiopathic hemolytic anemia}} | {{Microangiopathic hemolytic anemia}} | ||
* If left untreated, 90% of [[patient]]s with [[[microangiopathic hemolytic anemia]] may die<ref name="pmid2062330">{{cite journal| author=Rock GA, Shumak KH, Buskard NA, Blanchette VS, Kelton JG, Nair RC | display-authors=etal| title=Comparison of plasma exchange with plasma infusion in the treatment of thrombotic thrombocytopenic purpura. Canadian Apheresis Study Group. | journal=N Engl J Med | year= 1991 | volume= 325 | issue= 6 | pages= 393-7 | pmid=2062330 | doi=10.1056/NEJM199108083250604 | pmc= | url=https://www.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pubmed&tool=sumsearch.org/cite&retmode=ref&cmd=prlinks&id=2062330 }} </ref>. | |||
* The prognosis can be improved with prompt treatment. Therapeutic [[plasmapheresis]] reduces mortality rate to 20%<ref name="pmid2062330">{{cite journal| author=Rock GA, Shumak KH, Buskard NA, Blanchette VS, Kelton JG, Nair RC | display-authors=etal| title=Comparison of plasma exchange with plasma infusion in the treatment of thrombotic thrombocytopenic purpura. Canadian Apheresis Study Group. | journal=N Engl J Med | year= 1991 | volume= 325 | issue= 6 | pages= 393-7 | pmid=2062330 | doi=10.1056/NEJM199108083250604 | pmc= | url=https://www.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pubmed&tool=sumsearch.org/cite&retmode=ref&cmd=prlinks&id=2062330 }} </ref>. | |||
==References== | ==References== | ||
{{Reflist|2}} | {{Reflist|2}} |
Revision as of 15:00, 30 January 2021
Microangiopathic hemolytic anemia Microchapters |
Differentiating Microangiopathic hemolytic anemia from other Diseases |
---|
Diagnosis |
Treatment |
Case Studies |
Microangiopathic hemolytic anemia natural history, complications and prognosis On the Web |
American Roentgen Ray Society Images of Microangiopathic hemolytic anemia natural history, complications and prognosis |
FDA on Microangiopathic hemolytic anemia natural history, complications and prognosis |
on Microangiopathic hemolytic anemia natural history, complications and prognosis |
Microangiopathic hemolytic anemia natural history, complications and prognosis in the news |
Blogs on Microangiopathic hemolytic anemia natural history, complications and prognosis |
Directions to Hospitals Treating Microangiopathic hemolytic anemia |
- If left untreated, 90% of patients with [[[microangiopathic hemolytic anemia]] may die[1].
- The prognosis can be improved with prompt treatment. Therapeutic plasmapheresis reduces mortality rate to 20%[1].
References
- ↑ 1.0 1.1 Rock GA, Shumak KH, Buskard NA, Blanchette VS, Kelton JG, Nair RC; et al. (1991). "Comparison of plasma exchange with plasma infusion in the treatment of thrombotic thrombocytopenic purpura. Canadian Apheresis Study Group". N Engl J Med. 325 (6): 393–7. doi:10.1056/NEJM199108083250604. PMID 2062330.